This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Apple says US appeals court should affirm judgment against AliveCor's antitrust claims

( October 15, 2024, 23:31 GMT | Official Statement) -- MLex Summary: Apple told a US appeals court that nothing in the antitrust laws allows a company with one preferred use of an old version of a product—and a specialized use at that—to scuttle innovation that makes the product better for others, asking that it affirm a summary judgment against AliveCor’s claims. “Apple did not separately revoke access to data; it updated its software so Workout Mode would report more accurate data generated by the new algorithm. That developers like AliveCor no longer received data generated by an old algorithm and instead received data from a new one wasn’t some separate anticompetitive decision—it was the product improvement itself,” it said. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections